Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Indexed incrossrefpubmed
Abstract
Background
Little is known about the general population prevalence or severity of DSM-IV mental disorders.
Objective
To estimate 12-month prevalence, severity, and comorbidity of DSM-IV anxiety, mood, impulse control, and substance disorders in the recently completed US National Comorbidity Survey Replication. DESIGN AND SETTING: Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using a fully structured diagnostic interview, the World Health Organization World Mental Health Survey Initiative version of the Composite International Diagnostic Interview.
Citation impact
12,115
total citations
- FWCI
- 346.01
- Percentile
- 100%
- References
- 64
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Comorbidity
- National Comorbidity Survey
- Anxiety
- Mood disorders
- Psychiatry
- Mood
- Population
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- RWRobert Wood Johnson FoundationAward: 044708
- JDJohn D. and Catherine T. MacArthur FoundationAwards: R01 DA016558, R13-MH066849
- JWJohn W. Alden Trust
- ELEli Lilly and Company
- PPfizer
- GGlaxoSmithKline
- WHWorld Health Organization
- HUHarvard University
- MSMichigan State University
- JHJohns Hopkins University
- UOUniversity of Pittsburgh
- SASubstance Abuse and Mental Health Services Administration
- COCollege of Engineering, Michigan State University
- PFPfizer FoundationAwards: R01-MH069864, R01 DA016558, R13-MH066849
- PAPan American Health Organization
- NINational Institute of Mental HealthAwards: U01-MH60220, R01 MH46376, MH46376, 90135190, R01-MH069864, MH60220, R01 MH49098, R13-MH066849
- NINational Institute on Drug AbuseAwards: R01 MH49098, R01 DA016558, 90135190, MH46376, R01 MH46376